PERSPECTIVE published: 24 June 2020 doi: 10.3389/fneur.2020.00664 Frontiers in Neurology | www.frontiersin.org 1 June 2020 | Volume 11 | Article 664 Edited by: Ricardo F. Allegri, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Argentina Reviewed by: Paolo Martelletti, Sapienza University of Rome, Italy Matilde Leonardi, Carlo Besta Neurological Institute (IRCCS), Italy Amos D. Korczyn, Tel Aviv University, Israel *Correspondence: Sonu Bhaskar sonu.bhaskar@health.nsw.gov.au † The COVID19 pandemic is causing an unprecedented public health crisis impacting healthcare systems, healthcare workers and communities. The COVID-19 Pandemic Health System REsilience PROGRAM (REPROGRAM) consortium is an international not-for-profit think-tank established to champion the safety of healthcare workers, policy development and advocacy for global pandemic preparedness and action Specialty section: This article was submitted to Dementia and Neurodegenerative Diseases, a section of the journal Frontiers in Neurology Received: 30 April 2020 Accepted: 03 June 2020 Published: 24 June 2020 Citation: Bhaskar S, Bradley S, Israeli-Korn S, Menon B, Chattu VK, Thomas P, Chawla J, Kumar R, Prandi P, Ray D, Golla S, Surya N, Yang H, Martinez S, Ozgen MH, Codrington J, González EMJ, Toosi M, Hariya Mohan N, Menon KV, Chahidi A and Mederer Hengstl S (2020) Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. Front. Neurol. 11:664. doi: 10.3389/fneur.2020.00664 Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium Sonu Bhaskar 1,2,3 *, Sian Bradley 1,4 , Simon Israeli-Korn 1,5 , Bindu Menon 1,6 , Vijay Kumar Chattu 1,7 , Pravin Thomas 1,8 , Jasvinder Chawla 1,9 , Rajeev Kumar 1,10 , Paolo Prandi 1,11 , Daniel Ray 1,12 , Sailaja Golla 1,13 , Nirmal Surya 1,14 , Harvey Yang 1,15 , Sandra Martinez 1,16 , Mihriban Heval Ozgen 1,17,18 , John Codrington 1,19 , Eva María Jiménez González 1,20 , Mandana Toosi 1,21 , Nithya Hariya Mohan 1,22 , Koravangattu Valsraj Menon 1,23 , Abderrahmane Chahidi 1,24,25,26 and Susana Mederer Hengstl 1,27 1 Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee † , 2 Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia, 3 Neurovascular Imaging Laboratory & NSW Brain Clot Bank, Ingham Institute for Applied Medical Research and South West Sydney Clinical School, The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia, 4 The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia, 5 Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan and Sackler School of Medicine, Movement Disorders Institute, Tel Aviv University, Tel Aviv-Yafo, Israel, 6 Department of Neurology, Apollo Hospitals, Nellore, India, 7 Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, 8 Department of Neurology, University Hospitals NHS Foundation Trust, Birmingham, United Kingdom, 9 Department of Neurology, Loyola University Medical Center & Hines VA Hospital, Chicago, IL, United States, 10 Department of Psychiatry, Hamad Medical Center, Qatar & Australian National University, Canberra, ACT, Australia, 11 Department of Neurology, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy, 12 Farr Institute of Health Informatics, University College London (UCL) & NHS Foundation Trust, Birmingham, United Kingdom, 13 Texas Institute for Neurological Disorders, Dallas, TX, United States, 14 Department of Neurology, Bombay Hospital & Medical Research Centre, and Epilepsy Foundation India, Mumbai, India, 15 Department of Neurology, Academic Hospital Paramaribo & Anton de Kom Universiteit van Suriname Faculteit der Medische Wetenschappen, Paramaribo, Suriname, 16 Department of Neurology, Hospital da Restauração, Recife, Brazil, 17 Department of Psychiatry, Parnassia Psychiatric Institute, The Hague, Netherlands, 18 Curium-Leiden University Medical Centre, Oegstgeest, Netherlands, 19 Department of Laboratory Medicine, Academic Hospital Paramaribo and Anton de Kom Universiteit van Suriname Faculteit der Medische Wetenschappen, Paramaribo, Suriname, 20 Department of Forensic Psychology, Forensic Psychology and Forensic Sciences Institute, Ministry of Justice, Granada, Spain, 21 LodeStone Center for Behavioral Health and Eastern Illinois University, Chicago, IL, United States, 22 Chengalpattu Medical College and Hospital, Chengalpattu, India, 23 Department of Psychiatry, South London and Maudsley NHS Foundation Trust, Kings Health Partners, London, United Kingdom, 24 ED 268, DR 178, Sorbonne Nouvelle University, Paris, France, 25 Moroccan Society of Neurophysiology, Marrakech, Morocco, 26 Morocco and Basic and Clinical Neurosciences Research Laboratory, University Medical School of Marrakech, Marrakech, Morocco, 27 Department of Neurology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a growing body of evidence has shown a strong association of COVID-19 with pre- and post- neurological complications. This has necessitated the need to incorporate targeted neurological care for this subgroup of patients which warrants further reorganization of services, healthcare workforce, and ongoing management of chronic neurological cases. The social distancing and the shutdown imposed by several nations in the midst of COVID-19 have severely impacted the ongoing care, access and support of patients with chronic neurological conditions such as Multiple Sclerosis, Epilepsy, Neuromuscular Disorders, Migraine, Dementia, and Parkinson disease. There is a